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Summary
Objective: To examine the effects of hypoxia-inducible factor-1a (HIF-1a) on the plasminogen activator’s (PA) activity and on the expression of
components of PA system in articular chondrocytes of rats.
Methods: Chondrocytes from rat knee joint cartilage were cultured under normoxic, hypoxic, CoCl2 simulated hypoxic, and interleukin-1b
(IL-1b)-stimulated conditions. siRNA targeting HIF-1a was transfected into cells cultured under hypoxic, simulated hypoxic, and IL-1b-stimu-
lated conditions to silence HIF-1a. PA activity was determined by the hydrolysis of the chromogenic substrate H-D-Val-Leu-Lys-pNA (S-2251).
The mRNA levels were measured by quantitative real-time reverse transcription polymerase chain reaction (RT-PCR). The intracellular/matrix-
associate protein levels were detected by Western blot and the soluble protein levels were measured by enzyme linked immunosorbent assay
(ELISA). Chromatin immunoprecipitation (CHIP) assay was performed to determine whether HIF-1a binds to the hypoxia response element
(HRE) of target genes.
Results: The enhancement of HIF-1a by CoCl2 resulted in a decrease of PA activity, and the silence of HIF-1a by siRNA led to an increase of
PA activity. The PA inhibitor-1 (PAI-1) mRNA and protein were increased by hypoxia or simulated hypoxia, which was reversed by the
siRNA2-mediated silencing of HIF-1a. CHIP assay further conﬁrmed that the induction of PAI-1 involved the binding of HIF-1a to the PAI-
1 promoter, while the enhancement or silencing of HIF-1a did not affect the expression of urokinase type PA (uPA), tissue type PA (tPA)
or uPA receptor (uPAR). Additionally, IL-1b stimulated both HIF-1a and PAI-1 in articular chondrocytes, and the IL-1b-mediated induction
of PAI-1 was inhibited partly by HIF-1a silencing.
Conclusion: HIF-1a may inhibit the PA activity through stimulating the expression of PAI-1 in normal articular chondrocytes. The inhibition of
HIF-1a in the PA activity of articular chondrocytes probably plays an important role in the maintenance of articular cartilage matrix.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The plasminogen activator (PA) system is mainly composed
of urokinase type PA (uPA), tissue type PA (tPA), uPA re-
ceptor (uPAR), and PA inhibitor-1 (PAI-1). Both uPA and
tPA are serine proteases that catalyze the conversion of
the proenzyme plasminogen (PLG) to the broad-spectrum
serine proteinase plasmin (PL)1 that degrades the extracel-
lular matrix (ECM) directly or indirectly through activation of
secreted matrix metalloproteinases (MMPs)2 PA is intensi-
ﬁed and activated through binding to a speciﬁc cell-bound
receptor uPAR, which is expressed on a variety of cell
types, including chondrocytes3 while PA is inactivated by
its speciﬁc inhibitor PAI-14 There is a growing body ofaThese authors contributed equally to this work.
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1494evidence to suggest that the PA system plays an important
role in the degradation procedure of osteoarthritis (OA)5e8.
Increased levels of PA system have been detected in OA
cartilage lesions5,6, and the PA dependent cartilage de-
struction has been demonstrated by several in vitro stud-
ies7,8. The recent appliance of gene-deﬁcient mice
showed that PLG deﬁciency leads to less severe arthritis
than wild-type mice using collagen-induced arthritis
model9,10. Besides, clinical improvement of patients with
OA was observed after intra-articular injection of urinary
trypsin inhibitor, which was shown to inhibit uPA11. All these
observations support the idea that the PA system is mainly
detrimental to cartilage integrity.
Within synovial joints, oxygen supply to articular
chondrocytes is very limited and depends on the dynamic
ﬂow of synovial ﬂuid during joints movement12,13. It has
been demonstrated that an oxygen gradient exists in carti-
lage from around 6% at the joint surface to 1% in the deep
layers14. The chondrocytes live in extreme micro-environ-
mental conditions facing continuous low oxygen tensions.
However, chondrocytes have been shown to be well adap-
ted to these conditions15,16. Recently, the hypoxia-inducible
Table I
siRNA targeting HIF-1a designed and chemically synthesized for transfection to chondrocytes
HIF-1a siRNA siRNA ID Targeted exon(s) Sequence (50e30)
Sense Antisense
siRNA1 52882 2, 3 GGAAACUUCUAGGUGCUGGtt CCAGCACCUAGAAGUUUCCtt
siRNA2 52968 14 GGAUACAUAUCUAGUGAACtt GUUCACUAGAUAUGUAUCCtt
siRNA3 199319 9 CCAGUUGAAUCUUCAGAUAtt UAUCUGAAGAUUCAACUGGtt
1495Osteoarthritis and Cartilage Vol. 17, No. 11factor-1a (HIF-1a) has been reported to play a major role in
mediating the transcriptional response to hypoxia17, leading
to the survival of mammal cells under low oxygen tension.
The relatively high constitutive expression of HIF-1a by
chondrocytes may be an important adaptation to survival
in the avascular-hypoxic environment of cartilage18.
A previous study conducted on rat hepatocytes has
shown that HIF-1a regulates the expression of PAI-1
through binding to the hypoxia response element (HRE)
of PAI-119. However, no study, to our knowledge, has inves-
tigated whether the PA activity is regulated by HIF-1a in
articular chondrocytes.
Additionally, proinﬂammatory cytokines are believed to
play a pivotal role in the initiation and development of OA
process, among which IL-1b appears prominent. It has
been reported that IL-1b may regulate the expression of
PA system in several cell types20,21. Interestingly, IL-1b
has also been suggested to lead to an up-regulation of
HIF-1a in OA chondrocytes22. However, whether HIF-1a
participates in the IL-1b-mediated regulation of PA system
also remains unclear in articular chondrocytes.
Thus, the present study was carried out to elucidate the
effects of HIF-1a on PA activity and the expression of PA
system, as well as the role of HIF-1a in the IL-1b-mediated
regulation of PA system.Materials and methodsCHONDROCYTES ISOLATION AND CULTUREChondrocytes were isolated from articular cartilage of the knee joints of
5-week-oldSprague-Dawley (SD) rats as described previously23. In brief, artic-
ular cartilage layers of the knee jointswereminced into small pieces,washed in
phosphate buffered sodium (PBS), and subsequently digested in 0.25% tryp-
sin containing ethylene diamine tetraacetic acid (EDTA) for 30 min and then in
0.2%collagenase II (Sigma,St. Louis,MO,USA) for 3 hat 37C.Chondrocytes
were washed in phosphate buffered sodium (PBS, centrifuged, and then
seeded at a density of 3 104 cells/cm2 in 25-cm2 ﬂasks. The cells were grown
in monolayer cultures in high-glucose Dulbecco’s modiﬁed Eagle’s medium
(DMEM, Gibco, Grand Island, NY, USA) supplemented with 10% heat-inacti-
vated fetal calf serum (FCS) (Hyclone, Logan, UT, USA), 2 mM L-glutamine,
25 mM 2-(4-(2-hydroxyethyl)-1-piperazinyl) ethanesulfonic acid (HEPES),
and 100 units/ml penicillin and streptomycin in a humidiﬁed 5% CO2 atmo-
sphere. The cells were cultured under 2% (hypoxia)24 or 20% (normoxia) oxy-
gen, respectively, balanced with N2 in a 3-Gas incubator (Binder, Tuttlington,Table I
The base sequences of primers and pro
Gene Forward primer (50e30) Reverse primer
HIF-1a GAAAGAGCCCGATGCCCT TGATATGATCGTGTCC
uPA TCACTGGCTTCGGACAAGAGA TCCAATGTGGGACTG
uPAR GTCCTGTTGGTCTTCTCCTTGTG CACGGTGCTCGGGAA
PAI-1 CCTCGGTGCTGGCTATGCT GTGCCCCTCTCACTG
tPA GGCCAAATGCCATCAAGCT CGTGGTATACTTCCC
GAPDH CAAGTTCAACGGCACAGTCAA TGGTGAAGACGCCAG
b-actin TCCTTCCTGGGTATGGAATC GCACTGTGTTGGCATGermany) in a humidiﬁed atmosphere. In a simulated hypoxic condition,
CoCl2 (150 mM; Sigma), a chemical inducer of HIF-1, was added to the cells in-
cubated under normoxia. To evaluate the effects of IL-1b, cells were treated
with 10 ng/ml of IL-1b (R&D Systems, Minneapolis, MN, USA)22.HIF-1a siRNA SYNTHESIS AND TRANSFECTIONPre-designed siRNAs (cat#AM16708A) targeting rat HIF-1a were de-
signed and chemically synthesized by Ambion (Austin, TX, USA), and three
different siRNAs (Table I) from different regions of HIF-1a gene were se-
lected. A non-targeting scramble siRNA (Ambion, Austin, TX, USA) that
was constructed with no signiﬁcant homology to sequences of any mamma-
lian genes, served as a negative control (siRNA-neg). The appropriate trans-
fection condition was optimized by the siRNA targeting glyceraldehyde
phosphate dehydrogenase (GAPDH) (GAPDH-siRNA, Ambion, Austin, TX,
USA). The transfection of siRNA was performed with the Lipofectamine
2000 (Lipo, Invitrogen, Carlsbad, CA, USA). To optimize the transfection
condition, the concentration of GAPDH-siRNA varied between 10 and
100 nM. The transfection procedure was conducted according to the manu-
factures’ instructions. Brieﬂy, cells were passaged and reseeded in six-well
plates at a density of 2 105 cells/well. Twenty-four hours later, GAPDH-
siRNA and Lipo were diluted by Opti-MEM I (Gibco, Grand Island, NY,
USA), mixed, and then added to each well. The silencing effect of
GAPDH-siRNA was determined by Western blot and quantitative real-time
reverse transcription polymerase chain reaction RT-PCR analyses. The
optimized condition was used in subsequent experiments.3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM
BROMIDE ASSAY FOR CELL VIABILITYAfter incubation in 96-well plates for 6 h, 24 h, 48 h, and 72 h, the cell
survival was quantiﬁed by the colorimetric MTT assay. In brief, cells were in-
cubated with 0.5 mg/ml MTT for 4 h at 37C. Then supernatant was removed
and 150 mg of dimethyl sulfoxide (DMSO) was added. Optical densities at
490 nm were measured using culture medium as a blank.QUANTITATIVE REAL-TIME RT-PCRAfter 24 h incubation, total RNA was isolated with TRIzol reagent (Invitro-
gen, Carlsbad, CA, USA) and treated with RNase-free DNase I (Takara,
Kyoto, Japan) to avoid genomic DNA contamination according to the manu-
facturers’ instructions. Samples with a 260:280 nm absorbance ratio of 1.9 or
greater were reverse-transcribed using a RevertAid First-Strand cDNA
Synthesis Kit (Fermentas, Lithuania) with random hexamer primer. PCR
ampliﬁcation of the cDNA template was performed using TaqMan Universal
PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on ABI PRISM
7500 sequence detection system (Applied Biosystems, Foster City, CA,
USA). PCR conditions were 50C for 2 min and 95C for 10 min followed
by 40 cycles of ampliﬁcation consisting of 95C for 15 s and 60C forI
bes for quantitative real-time PCR
(50e30) Taqman MGB probe (50e30)
CCAGC FAM-ACTCTGCTAGCTCCAGC-MGB
AATCCA FAM-TGCTCGGAGATTCAGGAGAGG
ACCTCTTA-MGB
TG FAM-TCACCACCTCCAGCTCCTCGGC-MGB
ATATTGAA FAM-ACCAACAGCAGGGAAAACCCGGC-MGB
TGCCTTAAA FAM-TACTGCAGAAACCCAGACCGA
GACGTG-MGB
TAGACTC FAM-TCTTCCAGGAGCGAGATCCCGCT
AACT-MGB
AGAGG FAM-CGGATGTCAACGTCACACTTCATGA-MGB
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Fig. 2. PA activity is given in [U/106 cells] and represents the sum of
activities of uPA and tPA in cell lysates. Values are meansSD of
triplicate experiments in each group. Statistically signiﬁcant
difference from normoxic untreated control values: *P< 0.05.
1497Osteoarthritis and Cartilage Vol. 17, No. 111 min. Reactions were run in triplicate, and results were averaged. Each
value was normalized to b-actin as the housekeeping gene to control of
variations in the amount of input cDNA. Table II shows the sequences of
PCR primers and Taqman probes used in this study. The relative expression
level of the genes was calculated using the DDCt method compared to cells
transfected control-siRNA25.WESTERN BLOTAfter 48 h incubation, total proteins were isolated from the cultured chon-
drocyte monolayers with a total protein extraction kit (Keygen, Nanjing,
China), and protein concentrations were detected by a bicinchoninic acid
(BCA) protein assay kit (Pierce, Rockford, IL, USA) according to the manu-
factures’ instructions. Thirty micrograms proteins from each sample were
separated on 8% dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred electrophoretically to polyvinylidene diﬂuoride
(PVDF) membranes (Millipore, Boston, MA, USA). Membranes were blocked
with 2% bovine serum albumin (BSA) in Tris-buffered saline containing 0.1%
Tween 20 (TBST) at room temperature for 1 h and then incubated for 2 h with
mouse anti-HIF-1a (1.0 mg/ml), rabbit anti-PAI-1 (1:500), rabbit anti-uPA
(1:400), rabbit anti-tPA (1:400), rabbit anti-uPAR (1:500), rabbit anti-GAPDH
(1:1000), and rabbit anti-b-actin (1:1000). Horseradish peroxidase-conju-
gated anti-mouse or anti-rabbit IgG was used as secondary antibody
(1:10,000 diluted in TBST with 2% BSA, incubated for 1 h). Bands were
scanned using a densitometer (GS-700; Bio-Rad Laboratories, Hercules,
CA, USA), and quantiﬁcation was performed using Quantity One 4.6.3 soft-
ware. The mouse anti-HIF-1a was purchased from R&D systems (Minneap-
olis, MN, USA) and all the other antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA).ELISA ANALYSISuPA, tPA, and PAI-1 protein contents in supernatant were measured using
the goat anti-rat uPA, tPA, and PAI-1 ELISA kit (ADl, San diego, CA, USA).
Fifty microliters of the media was transferred to the microtest strip well of the
ELISA kit, and further procedures were performed following themanufacture’s
instructions. The intensity of color was measured at 450 nm in a microtest
plate spectrophotometer. The concentration of protein in culture media was
determined in triplicate wells and was normalized to total protein isolated
from the cultured chondrocytes and detected by BCA as described above.DETERMINATION OF PA ACTIVITYConversion of PLG to PL by PA in cell lysates was determined by the
hydrolysis of the chromogenic substrate H-D-Val-Leu-Lys-pNA (S-2251,
KabiVitrum, Stockholm, Sweden) as described previously26. Brieﬂy, cells
were lysed by repeated freezing and thawing and then mixed with PLGFig. 1. (A) The total RNA was extracted at 24 h after transfection and the H
The HIF-1a mRNA was normalized against b-actin and indicated % indu
cells under normoxia. Values are meansSD of three independent cul
untreated control values: *P< 0.05. (B) The total protein was extracted at
by Western blot. The b-actin levels were used as the internal controls. Va
The growth curve of chondrocytes in different groups. HIF-1a-deﬁcient ch
than the other cells. Values are meansSD of trip(1.3 mM; Sigma, St. Louis, MO, USA), S-2251 (0.7 mM), and Tris buffer
(50 mM Tris and 0.05% Tween 80, pH 8.0). The optimal density (OD) was mea-
sured in a microtest plate spectrophotometer. The PA activity was quantiﬁed
with a calibration curve using human urokinase (Sigma, St. Louis, MO, USA)
as a standard and was given in units according to international standards.CHROMATIN IMMUNOPRECIPITATION (CHIP) ASSAYCHIP assay was performed using a CHIP assay kit (Upstate Biotechnol-
ogy, Waltham, MA, USA) according to the manufacturer’s instructions.
Brieﬂy, cells were ﬁxed with formaldehyde, lysed, and sonicated to obtain
DNA fragments in a size from 200 to 1000 bp. Chromatin was then precipi-
tated with non-speciﬁc IgG antibodies (Sigma, St. Louis, MO, USA) or mouse
anti-HIF-1a (R&D systems, Minneapolis, MN, USA). DNA was extracted by
phenolechloroform and precipitated by ethanol. PCR was performed with
primers for a PAI-1 promoter fragment without HRE (fw: 50-TCGGAGACTG-
CAGCAGCCTGATC-30; rv: 50-AGGGTCGTTCAATGACCCTCCCT-30), and
for a fragment containing HRE (fw: 50-TCCCAGCAAGTTACTGGGAGGGA-
30; rv: 50-GTGAGAGGGCATGGGGGATAATTG-30) at 55C for 35 cycles.STATISTICAL ANALYSISAll experimental results are presented as means standard deviation
(SD). A parametric one-way analysis of variance (ANOVA) using SPSS
13.0 was used to test for any differences among the groups. If the result
was signiﬁcant, the Dunn’s Multiple Comparison Test was then used to
determine the speciﬁc differences between groups. P< 0.05 was considered
to be statistically signiﬁcant.ResultsTRANSFECTION CONDITION OPTIMIZATION AND HIF-1
a-siRNAS SELECTIONThe optimal concentration of siRNA was determined to be
30 nM, at which the expression of GAPDH reduced to
12.32% of mRNA level and 20.02% of protein level,
whereas siRNA-GAPDH at 50 and 100 nM caused non-
speciﬁc reduction of b-actin, and siRNA at 10 nM did not
signiﬁcantly affect the target gene. Of three HIF-1a-siRNAs
tested, the most efﬁcient one was found to be siRNA2,
which reduced HIF-1a mRNA level to about 9.7%
[Fig. 1(A)], and protein level to about 22.44% [Fig. 1(B)] at
24 h after transfection, compared to siRNA-neg-treated
cells. Thus, siRNA2 was used in subsequent experiments.HIF-1a EXPRESSION IN CHONDROCYTESIn the untreated control groups, cells cultured under hyp-
oxia revealed a signiﬁcant increase of HIF-1a mRNA
[Fig. 1(A)] and protein [Fig. 1(B)] compared with those cul-
tured under normoxia. Under normoxic condition, CoCl2
did not affect the HIF-1a mRNA expression [Fig. 1(A)] but
caused an enhancement of HIF-1a protein [Fig. 1(B)]. In
both hypoxic and simulated hypoxic conditions, HIF-1a
mRNA [Fig. 1(A)] and protein levels [Fig. 1(B)] were signif-
icantly reduced by the transfection of siRNA2.CELL VIABILITYUnder hypoxic conditions, HIF-1a-deﬁcient chondrocytes
(siRNA2 treated chondrocytes) showed a signiﬁcantIF-1a mRNA level was analyzed by quantitative real-time RT-PCR.
ction or reduction compared with HIF-1a mRNA levels in untreated
ture experiments. Statistically signiﬁcant difference from normoxic
48 h after transfection, and the HIF-1a protein level was measured
lues are meansSD of three independent culture experiments. (C)
ondrocytes under hypoxia had a signiﬁcantly lower proliferation rate
licate experiments in each group: *P< 0.05.
1498 G. Zhu et al.: Role of HIF-1a in the regulation of PA activity
Fig. 4. To detect binding of HIF-1 to the PAI-1 promoter, a CHIP assay was performed with the PAI-1 promoter fragment containing the HRE
and a promoter fragment containing no HRE as a control (non-HRE). Input DNA that is not enriched by immunoprecipitation is ampliﬁed as
positive control.
1499Osteoarthritis and Cartilage Vol. 17, No. 11decrease of cell conﬂuence in comparison with siRNA-neg-
treated chondrocytes. MTT assay showed that, under hyp-
oxic conditions, HIF-1a-deﬁcient chondrocytes had a signif-
icantly lower proliferation rate than the siRNA-neg-treated
chondrocytes [Fig. 1(C)]. Under normoxic conditions, there
was no statistical signiﬁcance in cell number between un-
treated control, CoCl2 treated chondrocytes, and
CoCl2þ siRNA2 treated chondrocytes.PA ACTIVITYWe measured the sum of uPA and tPA activities (Fig. 2).
In untreated control groups, the PA activity in the cells
cultured under hypoxia was equal to that in those cultured
under normoxia. Under normoxic conditions, a signiﬁcant
decrease of PA activity was obtained in chondrocytes
treated with CoCl2, which caused a signiﬁcant
enhancement of HIF-1a protein. This reduction, however,
was reversed by siRNA2 transfection. Under hypoxic condi-
tions, HIF-1a-deﬁcient chondrocytes revealed increased
amounts of PA activity compared with siRNA-neg-treated
chondrocytes.mRNA LEVELS OF THE COMPONENTS OF PA SYSTEMThe mRNA levels of PA system were measured by quan-
titative real-time RT-PCR [Fig. 3(A)]. The mRNA levels of
uPAR and PAI-1 were signiﬁcantly increased in chondro-
cytes cultured under hypoxia (untreated control group) in
comparison with chondrocytes cultured under normoxia
(untreated control group) [Fig. 3(A)]. The expression of
uPAR and PAI-1 was increased to 3.72-fold and 4.28-fold,
respectively. Under hypoxic conditions, the up-regulation
of PAI-1 mRNA was signiﬁcantly reversed by siRNA2 trans-
fection, while that of uPAR remains stable. Under normoxic
conditions, the PAI-1 mRNA was signiﬁcantly increased toFig. 3. (A) The total RNA was extracted at 24 h after transfection and the m
titative real-time RT-PCR. The mRNA levels were normalized against b-a
untreated cells under normoxia. Values are meansSD of triplicate expe
control values: *P< 0.05. (B) Intracellular/matrix-associate protein levels o
normalized by b-actin at 48 h after transfection. (C) The soluble protein
ELISA analysis. The soluble protein levels were determined in triplicate we
from normoxic untreated con3.88-fold by CoCl2. This induction, however, was
signiﬁcantly reversed by siRNA2 transfection. There
was no statistical signiﬁcance in either uPA or tPA mRNA
expression among all groups.INTRACELLULAR/MATRIX-ASSOCIATE AND SOLUBLE
PROTEIN LEVELS OF PA SYSTEMThe intracellular/matrix-associate and soluble protein
levels of PA system were determined by Western blot
[Fig. 3(B)] and ELISA [Fig. 3(C)], respectively. An increase
in intracellular/matrix-associate uPAR was observed in
chondrocytes cultured under hypoxic conditions compared
with that in those cultured under normoxic conditions. The
expression of intracellular/matrix-associate uPAR protein
was not affected by either CoCl2 or siRNA2 treatment
[Fig. 3(B)]. Consistent with the quantitative real-time RT-
PCR results, the intracellular/matrix-associate and soluble
PAI-1 proteins were induced by CoCl2 and hypoxia treat-
ments, and these inductions were reversed by siRNA2 treat-
ment [Fig. 3(B, C)]. The expression of intracellular/matrix-
associate uPA and tPA proteins in chondrocytes cultured
under hypoxic condition was comparable to those
cultured under normoxic conditions [Fig. 3(B)]. However,
the secreted levels of uPA and tPA in chondrocytes cultured
under hypoxic conditions were signiﬁcantly lower than those
in chondrocytes cultured under normoxic conditions
[Fig. 3(C)]. Neither intracellular/matrix-associate nor se-
creted uPA/tPA was affected by CoCl2 or siRNA2 treatment.BINDING OF HIF-1a WITH PAI-1 HREHIF-1a regulates the transcription of target genes usually
via binding to HRE. To conﬁrm the conclusion from the ex-
periments above indicating HIF-1a regulating the expres-
sion of PAI-1, CHIP assay was performed using anRNA levels of uPA, tPA, uPAR and PAI-1 were analyzed by quan-
ctin and indicated % induction or reduction compared with those in
riments. Statistically signiﬁcant difference from normoxic untreated
f uPA, tPA, uPAR, and PAI-1 were measured by Western blot, and
levels of uPA, tPA and PAI-1 in the supernatant were analyzed by
lls and normalized to total protein. Statistically signiﬁcant difference
trol values: *P< 0.05.
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tions. As shown in Fig. 4, the PCR products of PAI-1 pro-
moter were only detected in the samples that expressed
high levels of HIF-1a protein. The PAI-1 promoter region
that does not contain HRE (non-HRE) could not be precip-
itated by HIF-1a antibodies, suggesting that HIF-1a specif-
ically binding to the HRE region of PAI-1 promoter.ROLE OF HIF-1a IN THE IL-1b-MEDIATED REGULATION OF PAI-1Based on the above result that PAI-1 was regulated di-
rectly only by HIF-1a, the role of HIF-1a in the pathway of
IL-1b-meditated regulation of PAI-1 was further analyzed.
As shown in Fig. 5, IL-1b signiﬁcantly stimulated mRNAs
[Fig. 5(A)] and proteins [Fig. 5(B)] of both HIF-1a and PAI-
1 under normoxic and hypoxic conditions, respectively.Fig. 5. To evaluate the role of HIF-1a in IL-1b-mediated regulation of PAI-
normoxia and hypoxia respectively. (A) The total RNA was extracted at 24
by real-time RT-PCR and normalized against b-actin. Statistically signiﬁca
protein was extracted at 48 h after treatment, and HIF-1a and PAI-1 prot
used as the internal controls. Values are meansSThis stimulation was signiﬁcantly inhibited by the treatment
of siRNA2. Although decreased compared with IL-1b-
treated cells, PAI-1 levels in normoxiaþ IL-1bþ siRNA2
and hypoxiaþ IL-1bþ siRNA2 groups were still higher
than those in untreated control group.Discussion
Previous studies have demonstrated a pivotal role for
HIF-1a in regulating cell growth and energy generation, as
well as in matrix molecules synthesis in hypoxic growth plate
cartilage24,27,28. However, the role of HIF-1a on the degen-
eration of articular cartilage remains unclear. In the present
study, we examined the effects of HIF-1a on the expression
of the components of PA system and PA activity in articular1, cells were treated by IL-1b alone or combined with siRNA2 under
h after treatment, and the levels of HIF-1a and PAI-1 were analyzed
nt difference from untreated control values: *P< 0.05. (B) The total
ein levels were measured by Western blot. The b-actin levels were
D of three independent culture experiments.
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tivity was signiﬁcantly reduced by the enhancement of HIF-
1a in normoxia, and was signiﬁcantly increased by the si-
lence of HIF-1a in hypoxia. We found that the mRNA and
protein levels of PAI-1 were signiﬁcantly increased in chon-
drocytes cultured under hypoxic and simulated hypoxic con-
ditions, and that this up-regulation of PAI-1 was reversed by
siRNA2-mediated silencing of HIF-1a. These results sug-
gest that the expression of PAI-1 might be regulated in an
HIF-1a dependent way. To conﬁrm this speculation, CHIP
assay was further applied, and it was revealed that the in-
duction of PAI-1 involved binding of HIF-1a to the PAI-1 pro-
moter. Meanwhile, we found that the enhancement or
silence of HIF-1a did not affect the expression of uPA, tPA
or uPAR. Thus, it is PAI-1 that mediates the variation of
PA activity caused by enhancement or silence of HIF-1a.
To our knowledge, the present study shows for the ﬁrst
time that HIF-1amay inhibit the PA activity through stimulat-
ing the expression of PAI-1 in articular chondrocytes.
It has been found that HIF-2a (another transcription factor
with similar gene and protein structures and regulation
mechanisms to HIF-1a) is expressed in mouse articular
chondrocytes29. It has been also reported that HIF-2a is es-
sential for hypoxic induction of chondrocytes phenotype in
human articular cartilage30. An HIF-2a dependent pathway
has been demonstrated in the hypoxic induction of PAI-1.
Meade and colleagues31 found that both HIF-1a and HIF-
2a play important and similar roles in hypoxia-mediated
stimulation of PAI-1 expression in human trophoblast
(HTR)-8/SVneo cells (a ﬁrst trimester extravillous tropho-
blast cell line). However, Carroll and Ashcroft32 demon-
strated that, in renal carcinoma cells, PAI-1 expression
was predominantly dependent on HIF-2a, while HIF-1a si-
lencing had no signiﬁcant effect on PAI-1 mRNA expres-
sion. Discrepancies among these results might be
attributed probably to the different cell types involved in
these studies. Our results suggest that, in articular chondro-
cytes, HIF-1a plays an important role in the hypoxic induc-
tion of PAI-1. However, whether HIF-2a is involved in the
hypoxic regulation of PAI-1 in articular chondrocytes needs
to be further explored.
Only binding to their receptor (uPAR) on the cell surface,
can uPA/tPA efﬁciently convert to the active two-chain
form33,34. Thus, uPAR plays an essential role in the activation
of uPA and tPA. In present study, we show that uPAR expres-
sion of rat articular chondrocytes was up-regulated by hyp-
oxia, similar to the ﬁndings of studies on endothelial
cells35,36. Moreover, our results also demonstrate that this
hypoxia-induction of uPAR is regulated through an HIF-1a in-
dependent pathway in articular chondrocytes. Graham and
coworkers reported that a heme protein dependent pathway
may contribute to the uPAR induction under hypoxia in human
umbilical vein endothelial cells35, while Kroon et al.36 recently
exhibited a contradictory result that shows a heme protein in-
dependent pathway in humanmicrovascular endothelial cells.
Hitherto, the deﬁnite mechanism by which hypoxia up-regu-
lates the expression of uPAR in articular chondrocytes is not
yet known and needs to be further examined.
In the present study, we found a dramatic decrease in the
amount of soluble uPA and tPA proteins in cells cultured un-
der hypoxia; however, there was no variation in the mRNA
and intracellular/matrix-associate protein expression of uPA
and tPA. This suggests that the syntheses of uPA and tPA
in chondrocytes cultured under hypoxia were compatible to
those cultured under normoxia. Besides, neither the silence
nor the enhancement of HIF-1a altered the intracellular/ma-
trix-associate protein and mRNA expression of uPA andtPA, indicating that the expression of uPA and tPA is not
mediated by HIF-1a. It is believed that uPA/tPA is taken
up by the cell only after activation and subsequent internal-
ization via bounding to its speciﬁc receptor uPAR36. Kroon
et al. demonstrated an increased binding of uPA to uPAR
in human microvascular endothelial cells, and that thus
a higher activation rate of uPA can efﬁciently deplete the
conditioned medium of uPA37. Therefore, the decrease of
soluble uPA and tPA proteins observed in our study might
be resulted from the enhancement of uPAR expression.
We observed that uPAR and PAI-1 were simultaneously
stimulated by hypoxia and that the PA activity under hyp-
oxia did not differ from the activity under normoxia. Theoret-
ically, the PA activity under hypoxia should be increased by
a higher expression of uPAR and consequently higher acti-
vation rate of uPA/tPA. However, this increase did not hap-
pen in our study, which may be attributed to the increment
of PAI-1 and subsequent inhibition of uPA/tPA activation.
Recently, Yudoh et al.22 reported that IL-1b can lead to
an up-regulation of HIF-1a protein and mRNA via PI 3-ki-
nase and p38 kinase. Consistent with their study, we also
detected a stimulatory effect of IL-1b on HIF-1a expression
under normoxic and hypoxic conditions respectively. More
importantly, our results show that the induction of PAI-1
by IL-1b is mediated partly by HIF-1a. These ﬁndings indi-
cate that, besides HIF-1a, there maybe exist other path-
ways that are involved in the regulation of PAI-1 by IL-1b.
Evidence from hepatocytes38 showed that PAI-1 expression
was stimulated by IL-1b through mitogen-activated protein
kinase (MAPK) pathways, which subsequently induced
the CCAATeenhancer binding protein (C/EBP).
A central role for HIF-1a in chondrocytes survival amidst
the hostile micro-environmental conditions of OA has been
characterized by Yudoh and colleagues22. Our results pro-
vide evidence that HIF-1amay inhibit the PA activity through
stimulating the PAI-1 in normal articular chondrocytes, which
indicates a role for HIF-1a in the maintenance of ECM of ar-
thritic cartilage under hypoxic conditions and IL-1b stimula-
tion. Given the pivotal role for HIF-1a in regulating cell
survival in OA, as well as in inhibiting PA activity, a therapeu-
tic implication of HIF-1a in OA is reasonable to assume.How-
ever, it remains to be established whether these changes of
normal articular chondrocytes observed in our study would
similarly occur in the chondrocytes of OA, as chondrocytes
in OA cartilage are facing more severe conditions.
Conﬂict of interest
None declared.Acknowledgments
This work was supported by the grant from National Natural
Science Foundation of China (30872889) and (30300391).
We acknowledge Mr Lou Qinyuan (Eli Lilly and Company,
USA) for his contribution to the language revision and edito-
rial assistance to this article.References
1. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y.
The plasminogen activator system: biology and regulation. Cell Mol
Life Sci 1999;56:104e32.
2. Rosso AD, Cinelli M, Guiducc S, Pignone A, Fibbi G, Margheri F, et al.
Deﬂazacort modulates the ﬁbrinolytic pattern and reduces uPA-
dependent chemioinvasion and proliferation in rheumatoid arthritis
synoviocytes. Rheumatology 2005;44:1255e62.
1502 G. Zhu et al.: Role of HIF-1a in the regulation of PA activity3. Slot O, Brunner N, Locht H, Oxholm P, Stephens RW. Soluble urokinase
plasminogen activator receptor in plasma of patients with
inﬂammatory rheumatic disorders: increased concentrations in rheu-
matoid arthritis. Ann Rheum Dis 1999;58:488e92.
4. Kruithof EKO, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of
a fast acting inhibitor of plasminogen activators in human plasma.
Blood 1984;64:907e13.
5. Busso N, Peclat V, So A, Sappino AP. Plasminogen activation in
synovial tissues: differences between normal, osteoarthritis, and rheu-
matoid arthritis joints. Ann Rheum Dis 1997;56:550e7.
6. Belcher C, Fawthrop F, Bunning R, Doherty M. Plasminogen activators
and their inhibitors in synovial ﬂuids from normal, osteoarthritis, and
rheumatoid arthritis knees. Ann Rheum Dis 1996;55:230e6.
7. Campbell IK, Piccoli DS, Roberts MJ, Muirden KD, Hamilton JA. Effects
of tumor necrosis factor alpha and beta on resorption of human
articular cartilage and production of plasminogen activator by
human articular chondrocytes. Arthritis Rheum 1990;33:542e52.
8. Oleksyszyn J, Augustine AJ. Plasminogen modulation of IL-1-stimulated
degradation in bovine and human articular cartilage explants. The role
of the endogenous inhibitors: PAI-1, alpha(2)-antiplasmin, alpha(1)-PI,
alpha(2)-macroglobulin and TIMP. Inﬂamm Res 1996;45:464e72.
9. Li J, Ny A, Leonardsson G, Nandakumar KS, Holmdahl R, Ny T. The
plasminogen activator/plasmin system is essential for development
of the joint inﬂammatory phase of collagen type II induced arthritis.
Am J Pathol 2005;166:783e92.
10. Cook AD, Braine EL, Campbell IK, Hamilton JA. Differing roles for
urokinase and tissue-type plasminogen activator in collagen induced
arthritis. Am J Pathol 2002;160:917e26.
11. Matsuo O, Tanaka S, Kikuchi H. Effect of urinary trypsin inhibitor on
osteoarthritis. Thromb Res 1988;52:237e45.
12. Lund-Olesen K. Oxygen tension in synovial ﬂuids. Arthritis Rheum 1970;
13:769e76.
13. O’Hara BP, Urban JP, Maroudas A. Inﬂuence of cyclic loading on the nu-
trition of articular cartilage. Ann Rheum Dis 1990;49:536e9.
14. Silver IA. Measurement of pH and ionic composition of pericellular sites.
Philos Trans R Soc Lond B Biol Sci 1975;271:261e72.
15. Rajpurohit R, Koch CJ, Tao Z, Teixeira CM, Shapiro IM. Adaptation of
chondrocytes to low oxygen tension: relationship between hypoxia
and cellular metabolism. J Cell Physiol 1996;168:424e32.
16. Pfander D, Gelse K. Hypoxia and osteoarthritis: how chondrocytes sur-
vive hypoxic environments. Curr Opin Rheumatol 2007;19:457e62.
17. Semenza GL. Hypoxia-inducible factor 1 and the molecular physiology
of oxygen homeostasis. J Lab Clin Med 1998;131:207e14.
18. Coimbra IB, Jimenez SA, Hawkins DF, Piera-Velazquez S, Stokes DG.
Hypoxia inducible factor-1 alpha expression in human normal and os-
teoarthritic chondrocytes. Osteoarthritis Cartilage 2004;12:336e45.
19. Kietzmann T, Roth U, Jungermann K. Induction of the plasminogen
activator inhibitor-1 gene expression by mild hypoxia via a hypoxia re-
sponse element binding the hypoxia-inducible factor-1 in rat hepato-
cytes. Blood 1999;94:4177e85.
20. Bechtel MJ, Reinartz J, Rox JM, Inndorf S, Schaefer BM, Kramer MD.
Upregulation of cell-surface-associated plasminogen activation in cul-
tured keratinocytes by interleukin-1b and tumor necrosis factor-a. Exp
Cell Res 1996;223:395e404.
21. Chung HW, Wen Y, Ahn JJ, Moon HS, Polan ML. Interleukin-1 beta reg-
ulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble
u-PA receptor, and plasminogen activator inhibitor-1 messenger ribo-
nucleic acid expression in cultured human endometrial stromal cells.
J Clin Endocrinol Metab 2001;86:1332e40.22. Yudoh K, Nakamura H, Masuko-Hongo K, Kato T, Nishioka K. Catabolic
stress induces expression of hypoxia-inducible factor (HIF)-1a in artic-
ular chondrocytes: involvement of HIF-1a in the pathogenesis of oste-
oarthritis. Arthritis Res Ther 2005;7:R904e14.
23. Tsukazaki T, Usa T, Matsumoto T, Enomoto H, Ohtsuru A, Namba H,
et al. Effect of transforming growth factor-b on the insulin-like growth
factor-I autocrine/paracrine axis in cultured rat articular chondrocytes.
Exp Cell Res 1994;215:9e16.
24. Brucker PU, Izzo NJ, Chu CR. Tonic activation of hypoxia-inducible
factor 1alpha in avascular articular cartilage and implications for met-
abolic homeostasis. Arthritis Rheum 2005;52:3181e91.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data us-
ing real-time quantitative PCR and the 2(Delta Delta C(T)) method.
Methods 2001;25:402e8.
26. Sadowski T, Steinmeyer J. Differential effects of nonsteroidal antiinﬂam-
matory drugs on the IL-1 altered expression of plasminogen activators
and plasminogen activator inhibitor-1 by articular chondrocytes. In-
ﬂamm Res 2002;51:427e33.
27. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M,
Johnson RS. Hypoxia in cartilage: HIF-1alpha is essential for
chondrocyte growth arrest and survival. Genes Dev 2001;15:
2865e76.
28. Pfander D, Cramer T, Schipani E, Johnson RS. HIF-1a controls extracel-
lular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 2003;
116:1819e26.
29. Stewart AJ, Houston B, Farquharson C. Elevated expression of hypoxia
inducible factor-2a in terminally differentiating growth plate chondro-
cytes. J Cell Physiol 2006;206:435e40.
30. Lafont JE, Talma S, Murphy CL. Hypoxia-inducible factor 2a is essential
for hypoxic induction of the human articular chondrocyte phenotype.
Arthritis Rheum 2007;56:3297e306.
31. Meade ES, Ma YY, Guller S. Role of hypoxia-inducible transcription fac-
tors 1a and 2a in the regulation of plasminogen activator inhibitor-1
expression in a human trophoblast cell line. Placenta 2007;28:
1012e9.
32. Carroll VA, Ashcroft M. Role of hypoxia-inducible factor (HIF)-1a versus
HIF-2a in the regulation of HIF target genes in response to hypoxia,
insulin-like growth factor-I, or loss of von HippeleLindau function: im-
plications for targeting the HIF pathway. Cancer Res 2006;66:
6264e70.
33. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev
Mol Cell Biol 2002;3:932e43.
34. Preissner KT, Kanse SM, May AE. Urokinase receptor: a molecular or-
ganizer in cellular communication. Curr Opin Cell Biol 2000;12:621e8.
35. Graham CH, Fitzpatrick TE, McCrae KR. Hypoxia stimulates urokinase
receptor expression through a heme protein-dependent pathway.
Blood 1998;91:3300e7.
36. Kroon ME, Koolwijk P, van der Vecht B, van Hinsbergh VW. Urokinase
receptor expression on human microvascular endothelial cells is in-
creased by hypoxia: implications for capillary-like tube formation in a ﬁ-
brin matrix. Blood 2000;96:2775e83.
37. Kroon ME, Koolwijk P, van Goor H, Weidle UH, Collen A, van der
Pluijm G, et al. Role and localization of urokinase receptor in the for-
mation of new microvascular structures in ﬁbrin matrices. Am J Pathol
1999;154:1731e42.
38. Dong J, Fujii S, Imagawa S, Matsumoto S, Matsushita M, Todo S, et al.
IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1
expression through independent signaling pathways converging on
C/EBPd. Am J Physiol Cell Physiol 2007;292:C209e15.
